ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Eitan Snir
Bernardo A. Vidne
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ad, N.
Right arrow Articles by Vidne, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ad, N.
Right arrow Articles by Vidne, B. A.

Ann Thorac Surg 1996;62:626-628
© 1996 The Society of Thoracic Surgeons


Correspondence

Unidirectional Valve Patch

Niv Ad, MD, Jacob Barak, MD, Einat Birk, MD, Eitan Snir, MD, Bernardo A. Vidne, MD

Departments of Cardiothoracic PPediatri Cardiology, Beilinson Medical Center, Petach Tikva 49100, Israel

To the Editor:

We read with great interest Zhou and colleagues' article entitled "Unidirectional Valve Patch for Repair of Cardiac Septal Defect With Pulmonary Hypertension" [1]. We congratulate the authors on their excellent results in this group of patients who present a particular challenge to every surgical team.

We would, however, like to remark on the omission of any reference to our work entitled "A One-Way, Valved, Atrial Septal Patch in the Management of Postoperative Right Heart Failure," which has been presented at several international scientific gatherings since 1989, including the Third World Cardiology Congress of Pediatric Cardiology held in Bangkok, Thailand in 1989 and in The Journal of Thoracic and Cardiovascular Surgery [2–4]. Furthermore, Dr David A. Fullerton, in his invited commentary, described Dr Zhou and colleagues' work as "...a very innovative technique," which is incorrect.

Our device (Fig 1Go) is fashioned in two layers, one of polytetrafluoroethylene cardiovascular patch and the other of woven Dacron. A central opening, 3 to 4 mm in diameter, is created in the polytetrafluoroethylene layer and covered by a second, smaller layer of woven Dacron ("curtain"), which is sutured to the polytetrafluoroethylene along one side only. This creates a simple, one-way valve. The device is sutured to the interatrial septum through the right atrium so that the curtain is facing the left atrium and closes toward the right atrium.



View larger version (53K):
[in this window]
[in a new window]
 
Fig 1. . One-way, valved, atrial septal patch.

 
The device was successfully tested in an animal model [2] before its use in humans. An article covering our clinical experience was published in The Journal of Thoracic and Cardiovascular Surgery [4]. This article covers the use of the one-way, valved, atrial septal patch in 18 patients who were followed up for between 3 months and 6 years. The patients in this study were divided into three different groups: group A consisted of 9 patients with congenital malformation characterized by a hypoplastic right ventricle and pulmonary stenosis or atresia. This group of patients runs a high risk of the development of perioperative right heart failure when biventricular repair is performed [5, 6]. The use of the one-way valve in this instance enabled us to perform a biventricular repair in all patients in this group with minimal risk of postoperative right heart failure. The biventricular repair was performed in patients with hypoplastic right ventricle with intact ventricular septum or ventricular septal defect, in patients with transposition of the great arteries and subpulmonary stenosis, and in borderline cases for a complete repair of tetralogy of Fallot. The operative results in this group were fairly good, with only 1 patient requiring subsequent univentricular repair due to severe cyanosis and right heart failure. There was no mortality.

Group B consisted of 6 patients, aged 2 to 59 years, with high pulmonary vascular resistance due to a large right-to-left shunt from an atrial or ventricular septal defect. In this group of patients, we agree with Dr Fullerton's comment that the degree of reversibility of the pulmonary vascular disease should be evaluated according to the pulmonary vascular resistance and not pulmonary vascular pressure to estimate the operative risk for a complete repair using the usual methods employed during cardiac catheterization [7]. During correction of the congenital malformation, the one-way, valved, septal atrial patch always was used in the interatrial septum. Right-to-left interatrial shunting was documented in all patients immediately on weaning from cardiopulmonary bypass. In all patients but 1, the device closed spontaneously during the first postoperative week (1 to 6 days). In 1 patient, a 23-year-old woman who had a large perimembranous ventricular septal defect with a fixed pulmonary vascular resistance of 7.1 U/m2, a progressive decrease in pulmonary artery pressure occurred over the first 8 postoperative months, with a significant improvement in right ventricular function. This led to a spontaneous closure of the device 8 months postoperatively. In addition, her general condition improved and she is now in New York Heart Association functional class I.

Group C consisted of patients with intraoperative acute right heart failure after complete repair of a congenital malformation. The right heart failure was resistant to maximal pharmacologic treatment, and the device was implanted as a last resort and only after repeated failures to wean them from cardiopulmonary bypass. In no patient in this group was there any morbidity that could be ascribed to the use of the one-way, valved, septal atrial patch. On discharge, all patients received aspirin as prophylaxis against thrombus formation on the device and subacute bacterial endocarditis prophylaxis. During the follow-up period, no thrombus formation or subacute bacterial endocarditis was documented.

Four weeks ago, a one-way, valved, septal ventricular patch was used at the level of the interventricular septum in a 31/2-year-old boy with tetralogy of Fallot and pulmonary atresia. The child had undergone three operations for left and right unifocalization through a bilateral thoracotomy, and was now being hospitalized for the final-stage operation. In this operation, the right and left sacks were connected using a 14-mm polytetrafluoroethylene tube and then connected to the right ventricle with a 19-mm pulmonary homograft. The ventricular septal defect was then closed with a one-way patch with the curtain facing toward the left ventricle. The curtain was kept in its closed position with three parallel side stitches. During the first 6 postoperative days, right-to-left interventricular shunting was documented, but not thereafter. In this instance, the one-way patch decompressed the failing right ventricle at the level of the ventricles and closed spontaneously when right ventricular pressure decreased. The curtain was sutured in such a way as to prevent it from becoming entrapped in the open position in the left ventricular cavity.

Based on our clinical experience, we believe that when indicated the use of the one-way, valved, atrial septal patch as part of the surgical repair may, in many cases, prevent postoperative right heart failure, ease the early postoperative course, and further improve operative results.

References

  1. Zhou Q, Lai Y, Wei H, Song R, Wu Y, Zhang H. Unidirectional valve patch for repair of cardiac septal defects with pulmonary hypertension. Ann Thorac Surg 1995;60:1245–9.[Abstract/Free Full Text]
  2. Ad N, Barak J, Birk E, Snir E, Vidne BA. A one-way, valved, atrial septal patch in the management of right heart failure: animal study. J Thorac Cardiovasc Surg 1994;108:134–9.[Abstract/Free Full Text]
  3. Ad N, Barak J, Birk E, Diamant S, Vidne BA. Valved atrial septal patch. Reply. J Thorac Cardiovasc Surg 1996;111:286.[Free Full Text]
  4. Ad N, Birk E, Barak J, Diamand S, Snir E, Vidne BA. A one way atrial septal patch: a new surgical technique and its clinical application. J Thorac Cardiovasc Surg 1996;111:841–8.[Abstract/Free Full Text]
  5. Kirklin JW, Blackstone EH, Shimasaki Y, et al. Survival, functional status and reoperation after repair of tetralogy of Fallot with pulmonary atresia. J Thorac Cardiovasc Surg 1988;96:102–16.[Abstract]
  6. De Leval MR, Bull C, Stark J, Anderson RH, Taylor JFN, Macartney FJ. Pulmonary atresia and intact ventricular septum: surgical management based on revised classification. Circulation 1982;66:272–80.[Abstract/Free Full Text]
  7. Steele PM, Fuster V, Cohen M, Ritter DG, McGoon DC. Isolated atrial septal defect with pulmonary vascular obstructive vascular disease: long term follow-up and prediction of outcome after surgical correction. Circulation 1987;76:1037–42.[Abstract/Free Full Text]




This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Eitan Snir
Bernardo A. Vidne
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ad, N.
Right arrow Articles by Vidne, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ad, N.
Right arrow Articles by Vidne, B. A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS